arrow
P

Polina Stepensky

hebrew university of jerusalem
H指数:45
被引数:7,290

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Viral Reactivation in Multiple Myeloma Patients Receiving Anti-BCMA Chimeric Antigen Receptor T-Cell Therapy

接受抗BCMA嵌合抗原受体T细胞治疗的多发性骨髓瘤患者的病毒再激活

2026-03-310
OAAI
High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T)

与BCMA靶向嵌合抗原受体T细胞(CAR-T)治疗相关的细胞因子释放综合征相关凝血功能障碍发生率高,而出血和血栓发生率低。

2025-11-020
OAAI
Trajectories from single-cells to PAX5-driven leukemia reveal PAX5-MYC interplay in vivo

从单细胞到PAX5驱动的白血病轨迹揭示了PAX5-MYC在体内的相互作用

LEUKEMIA
IF13.4
2025-05-200
OA
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT) Outcomes in Leukocyte Adhesion Deficiency Type-I

白细胞粘附缺陷症I型的异基因造血干细胞移植(allo-HSCT)结局

BLOOD
IF23.1
2024-11-050
PRE
Inborn errors of immunity reveal molecular requirements for generation and maintenance of human CD4+ IL-9-expressing cells

原发性免疫缺陷揭示了产生和维持人类CD4+ IL-9表达细胞的分子需求

2024-11-010
PRE
Clinical evaluation and determinants of response to HBI0101 (BCMA CART) therapy in relapsed/refractory multiple myeloma
2024-07-311
PRE
Sclerotic-Type Cutaneous Chronic Graft-VersusHost Disease Exhibits Activation of T Helper 1 and OX40 Cytokines
2024-03-012
OAAI
Long-term and real-world safety and efficacy of retroviral gene therapy for adenosine deaminase deficiency
2024-02-145
OA
Management of Atopy with Dupilumab and Omalizumab in CADINS Disease
2024-01-171
PRE
Defibrotide plus best standard of care compared with best standard of care alone for the prevention of sinusoidal obstruction syndrome (HARMONY): a randomised, multicentre, phase 3 trial

Defibrotide联合最佳护理标准与单独最佳护理标准预防肝窦阻塞综合征 (HARMONY) 的比较: 一项随机、多中心、3期临床试验

2023-05-0120
PRE
Ibrutinib Treatment of Pediatric Chronic Graft-versus-Host Disease: Primary Results from the Phase 1/2 iMAGINE Study

依鲁替尼治疗小儿慢性移植物抗宿主病: 1/2期iMAGINE研究的主要结果

2022-11-0115
OAAI